Saturday, December 6, 2025

Rigetti Computing Shares Jump 5% After Investment Firm Raises Price Target to $17

Rigetti Computing's stock surged 5% after a price target upgrade, reflecting a 1,122% increase over six months in quantum computing.

South Korean Military Strengthens Defense with Full Operationalization of 425 Project Satellites

South Korea's military will launch five reconnaissance satellites by 2025, enhancing capabilities to monitor North Korea's activities.

Despite Broad Selloff, NVIDIA Posts 1% Gain Fueled by AI Growth

U.S. stocks fell due to inflation fears, but NVIDIA rose amid Amazon's $100 billion AI investment, while other chip stocks declined.

Tag: diabetes

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Rising Use of GLP-1 Drugs May Be Linked to Rare Pancreatitis Cases, Study Finds

Reports of acute pancreatitis linked to GLP-1 diabetes drugs surge in the UK, prompting investigations and conflicting academic findings.

One in Three Diabetes Patients at Risk for Kidney Disease, Study Finds

Diabetes can lead to kidney disease, affecting one in three patients. Early detection and nephrology care are crucial for better outcomes.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Diabetes Risk for 40% of Adults: How a New Nutrition Guide is Helping

Korea's Food and Drug Safety Ministry launched a guide for prediabetes management, improving dietary habits for better health outcomes.

Study Reveals Semaglutide Reduces Cravings and Helps Control Weight and Blood Sugar

A study shows oral semaglutide aids weight loss and reduces cravings for sugary foods in type 2 diabetes patients.

Study Reveals: Taking Statins for 3 Years Can Slash Dementia Risk by 63%!

A study reveals statins can reduce dementia risk by 63%, especially in diabetic patients, highlighting their protective benefits.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.